Because TLR2 and TLR4 are expressed on the endothelium and implicated in angiogenesis independent of VEGF, biglycan might stimulate tumour angiogenesis through TLR2 and TLR4 activation (Grote et al, 2010; West et al, 2010). The gene discussed is VEGFA; the disease is neoplasm.